Home / Physicians / Physician Tests / MI Profile

MI Profile

Comprehensive profiling that assesses DNA, RNA and proteins from tumor tissue to reveal a more complete picture to help tailor treatment plans for patients with solid tumor cancers

Order Now

6-9 days

Average testing turnaround time upon specimen receipt

23,000+ genes

Simultaneously analyzed using Whole Exome Sequencing (WES) + Whole Transcriptome Sequencing (WTS)

25+ tumor-relevant protein biomarkers

Available globally

*Excluding USA, EEA, EU, CH countries

What it is:

MI Profile® tests include next-generation sequencing (NGS), immunohistochemistry (IHC), chromogenic in situ hybridization (CISH), pyrosequencing and AI-predictive algorithms for select tumor types.

Why it matters:

The result is a complete molecular blueprint that helps guide precise and individualized treatment decisions.

TESTING WORKFLOW

How MI Profile Works

Tumor Tissue Collected

A tissue sample is collected during a biopsy or surgical removal of your tumor.

DNA and RNA Sequencing Performed

Simultaneous WES/WTS delivers a more complete picture of the biomarkers driving your cancer.

Genomic Alterations Identified

Advanced bioinformatics identifies clinically relevant genomic alterations and molecular signatures from DNA and RNA sequencing data.

Clinical Report Delivered

Results are delivered to the ordering physician within 6-9 days of specimen receipt, providing molecular insights to help personalize treatment based on your cancer.

Test results

Complete Molecular Intelligence® Report

The Caris Molecular Profiling Report delivers high-impact results, including potentially relevant, actionable clinical information, in an easy-to-interpret format. Every report includes access to the Caris+®Portal and the Clinical Trials Connector™, which matches each patient’s unique biomarker expression profile to open, pertinent clinical trial opportunities.

Actionable Insights from Tissue